RA MEDICAL SYSTEMS INC (RMED) Stock Price, Forecast & Analysis
USA - NYSEARCA:RMED - US74933X3026 - Common Stock
RMED Key Statistics, Chart & Performance
The current stock price of RMED is 0.594 USD. In the past month the price decreased by -13.28%. In the past year, price decreased by -92.68%.
RMED Latest News, Press Relases and Analysis
RMED Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.32 | 219.92B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.04 | 200.75B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.91 | 148.20B | ||
| SYK | STRYKER CORP | 27.03 | 136.11B | ||
| IDXX | IDEXX LABORATORIES INC | 56.18 | 56.68B | ||
| BDX | BECTON DICKINSON AND CO | 12.33 | 50.97B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.45 | 48.96B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.92 | 33.35B | ||
| PODD | INSULET CORP | 75.61 | 22.51B | ||
| DXCM | DEXCOM INC | 29.57 | 21.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.94 | 17.53B |
Related stock screener links
About RMED
Company Profile
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures. The Company’s product includes Ventricular Onset System (VIVO), LockeT and Amigo Remote Catheter System. Its VIVO is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its VIVO utilizes non-invasive inputs to locate the origin of ventricular arrhythmias. VIVO uses standard clinical inputs, such as a CT or MRI and a 12 lead ECG, both of which are routinely gathered for EP procedures, allowing VIVO to seamlessly integrate into the workflow. A 3D photograph is obtained of the patient’s torso after the ECG leads are in place and all of these clinical inputs are combined to generate a 3D map of the patient’s heart with a location of the earliest onset of the ventricular arrhythmia.
Company Info
RA MEDICAL SYSTEMS INC
1670 Highway 160 West, Suite 205
Fort Mill SOUTH CAROLINA 92011 US
CEO: Jonathan Will McGuire
Employees: 14
Phone: 19736912000.0
RA MEDICAL SYSTEMS INC / RMED FAQ
Can you describe the business of RA MEDICAL SYSTEMS INC?
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina and currently employs 14 full-time employees. The company went IPO on 2018-09-27. The firm is focused on developing technology for electrophysiology (EP) procedures. The Company’s product includes Ventricular Onset System (VIVO), LockeT and Amigo Remote Catheter System. Its VIVO is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its VIVO utilizes non-invasive inputs to locate the origin of ventricular arrhythmias. VIVO uses standard clinical inputs, such as a CT or MRI and a 12 lead ECG, both of which are routinely gathered for EP procedures, allowing VIVO to seamlessly integrate into the workflow. A 3D photograph is obtained of the patient’s torso after the ECG leads are in place and all of these clinical inputs are combined to generate a 3D map of the patient’s heart with a location of the earliest onset of the ventricular arrhythmia.
Can you provide the latest stock price for RA MEDICAL SYSTEMS INC?
The current stock price of RMED is 0.594 USD. The price increased by 10% in the last trading session.
What is the dividend status of RA MEDICAL SYSTEMS INC?
RMED does not pay a dividend.
How is the ChartMill rating for RA MEDICAL SYSTEMS INC?
RMED has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in RA MEDICAL SYSTEMS INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on RMED.
What is the employee count for RMED stock?
RA MEDICAL SYSTEMS INC (RMED) currently has 14 employees.
What is the market capitalization of RMED stock?
RA MEDICAL SYSTEMS INC (RMED) has a market capitalization of 4.16M USD. This makes RMED a Nano Cap stock.
RMED Technical Analysis
RMED Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RMED. While RMED seems to be doing ok healthwise, there are quite some concerns on its profitability.
RMED Financial Highlights
Over the last trailing twelve months RMED reported a non-GAAP Earnings per Share(EPS) of -45.97. The EPS increased by 73.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
RMED Forecast & Estimates
7 analysts have analysed RMED and the average price target is 7.14 USD. This implies a price increase of 1102.02% is expected in the next year compared to the current price of 0.594.
For the next year, analysts expect an EPS growth of 52.85% and a revenue growth 13964.3% for RMED